HomeOrthoSpin Ltd.

OrthoSpin Ltd.

OrthoSpin Announces Its G2 System Received FDA Regulatory Clearance

The Company has completed initial clinical cases in the U.S. and Israel with the FDA-cleared OrthoSpin Generation 1 system. Read more.

Successful First in Human for OrthoSpin’s Robotic External Orthopedic Fixation System

2/28/18: OrthoSpin Ltd. ("OrthoSpin"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T; OTCQX: TRNLY), announced that it successfully completed a first-in-human (FIH) case for its smart, robotic external fixation system for the treatment of an orthopedic deformity.